Dunkin’ Brands (DNKN) Beats Q2 Earnings Estimates, Sales Lag

Dunkin’ Brands (DNKN) Beats Q2 Earnings Estimates, Sales Lag

Shares of Dunkin’ Brands Group, Inc. (DNKN – Free Report) were up nearly 2% in the trading session on Jul 27, after the company reported mixed second-quarter 2017 results. While, the bottom line outpaced the Zacks Consensus Estimate, the top line lagged the same. Earnings and Revenues Discussion Adjusted earnings of 64 cents per share beat the Zacks Consensus […]
The “Real” Goods On The June Durable Goods Data

The “Real” Goods On The June Durable Goods Data

Earlier today the Census Bureau posted the Advance Report on the latest Durable Goods New Orders. This series dates from 1992 and is not adjusted for either population growth or inflation. Let’s now review Durable Goods data with two adjustments. In the charts below the gray line shows the goods orders divided by the Census Bureau’s monthly […]
Mediocre, Tailing 7 Year Auction Following Yesterday’s Short Squeeze

Mediocre, Tailing 7 Year Auction Following Yesterday’s Short Squeeze

After two surprisingly strong auctions earlier in the week, when the Treasury sold both 2 and 5 Year paper to unexpectedly brisk demand ahead of the FOMC meeting, which bounced despite a record high short interest in 2Y futs, moments ago the last auction of the week closed when $28 billion in 7 Year paper was sold […]
GBP/USD Elliott Wave Forecast: Bearish Impulse Wave

GBP/USD Elliott Wave Forecast: Bearish Impulse Wave

Elliott Wave Forecast GBP/USD Short Term Bearish trend is present in GBP/USD currency pair, 15 minutes chart. As I have suggested a few hours ago, during my daily Forex Live Trading Room session, the price of GBP/USD currency pair is falling down on a short-term basis to create a Bearish Impulse Elliott wave pattern and […]
General Dynamics: Another Solid Quarter, Overvaluation Persists

General Dynamics: Another Solid Quarter, Overvaluation Persists

Part-way through earnings season, the outlook remains bright. Many of the most high-quality dividend stocks have beat expectations, and corporate earnings seem to be growing at a rate higher than previous expectations (although time will tell if this trend holds). On July 26, General Dynamics (GD) reported earnings for the three-month period ending July 2, […]
USD/CAD: Is A Low In Place? US, Canada GDP On Deck

USD/CAD: Is A Low In Place? US, Canada GDP On Deck

USD/CAD Daily Chart   Technical Outlook: USD/CAD reversed sharply today off confluence support at 1.2415 (low was 1.2413) – this level is defined by a long-term 61.8% ext of the broader decline off the 2016 high and converges on a parallel support extending off the 9/21 swing low (red). Note that daily momentum is also attempting to break […]
There’s A Storm A Comin’

There’s A Storm A Comin’

Bloomberg interviewed Alicia Munnell from the Boston College Center for Retirement Research. She of course has come to be a thought leader for what ails the Social Security system. Shockingly it boils down to three things; cutting benefits, raising the cap one way or another or some combo of both. I’ve framed it numerous times by saying […]
Durable Goods New Orders Improves In June 2017

Durable Goods New Orders Improves In June 2017

The headlines say the durable goods new orders improved. The unadjusted three month rolling average improved. .Analyst Opinion of the Durable Goods Situation Our analysis is more positive than the headlines as we see improvement this month. Civilian aircraft were the main headwind this month. If one removes aircraft – this is a soft report. […]
Great Graphic: CRB Index Hits 2017 Down Trendline

Great Graphic: CRB Index Hits 2017 Down Trendline

The CRB Index gapped higher today and it follows a gap higher opening on Tuesday, which has not been filled. Today’s gains lift the commodity index to a trendline drawn off the January and February highs and catches the high from late May. It intersects today near 181.35 and the high has been a little over […]
AstraZeneca Plunges Following Failed Lung Cancer Study

AstraZeneca Plunges Following Failed Lung Cancer Study

Shares of AstraZeneca (AZN) are dropping sharply after the company said its MYSTIC trial failed to show its two-drug combination extended progression-free survival compared with standard-of-care chemotherapy for lung cancer patients. Leerink analyst Seamus Fernandez downgraded the stock to Market Perform following the news, while noting that this could have a negative read-through for Bristol-Myers […]